Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey

PURPOSE: International guidelines vary in their recommendations whether or not to reduce the therapeutic dose of low molecular weight heparins (LMWHs) in renal impairment. The use of anti-Xa monitoring as a basis of dose adjustments is also a matter of debate. As this may lead to variations in treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaspers, Tessa Corrine Catherina, Keyany, A., Maat, B., Meijer, K., van den Bemt, P. M. L. A., Khorsand, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365729/
https://www.ncbi.nlm.nih.gov/pubmed/35715569
http://dx.doi.org/10.1007/s00228-022-03344-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365729/
https://www.ncbi.nlm.nih.gov/pubmed/35715569
http://dx.doi.org/10.1007/s00228-022-03344-9

Ejemplares similares